This SPA allows West Virginia to enter into Outcome/Value-Based Supplemental Rebate Agreements with drug manufacturers on a voluntary basis. In addition, this SPA allows coverage of medically necessary prescribed drugs that are not covered outpatient drugs, including drugs authorized for import by the U.S. Food and Drug Administration (FDA), during drug shortages.
State
Approval Date
Effective Date
File 1 - Approval Document Media